Tanke Biosciences Corp (TNBI)

PriceLoading quote

Financial charts

Revenue

Net income

Free cash flow

Total cash / debt

CashTotal debt

Financial statements

4 annual periodsNewest to oldest
2012201120102009
Revenue$28.6M$23.8M$20.1M
Gross profit$9.9M$8.8M$7.4M
Research & development$290,691$246,038
Operating income$4.5M$1.7M$4.4M
EBITDAderived$5.2M$2.1M$4.5M
Net income−$210,247−$3.1M$2.7M$2.6M
Basic EPSper diluted share-$0.02-$0.24$0.34
Diluted EPSper diluted share-$0.02-$0.24$0.34

Insider buys & sells

Jul 1, 2024Jun 30, 2026
Buys0$0.00 disclosed value
Sells (SEC code S)0$0.00 disclosed value
0 recent transactions
No insider transactions transactions were reported in the stored SEC coverage.